Skip to content
Screener

Stryker SYK MedSurg and Neurotechnology: — Net Sales

Other segment segments

Orthopaedics:
$2.81B+0.1%
Orthopaedics
$2.17B—

Similar metrics at other companies

Boston Scientific logo
BSXMedSurg — Net Sales
$1.82B+5.9%
Central Garden & Pet Company logo
CENTPet — Net Sales
$476.84M+5.1%
CF Industries logo
CFAN — Net Sales
$58M-42.6%
Otis Worldwide logo
OTISNew Equipment — Net Sales
$1.28B+0.2%
DCH
DCHCorporate and Eliminations — Net Sales
$0—
Moog Inc. logo
MOG.ASpace And Defense — Net Sales
$313.59M+16.1%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%—
Debt / equity0.8×—
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Net Sales by BusinessThree Months / 2026Three Months / 2025
Endoscopy868867
Medical902945
Vascular517406
$3,207$3,056
Orthopaedics:
Knees$670$639
Hips460443
Trauma and Extremities1,035945

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's medsurg and neurotechnology: — net sales?
Stryker (SYK) reported medsurg and neurotechnology: — net sales of $3.21B in Q1 2026.
How has Stryker's medsurg and neurotechnology: — net sales changed year-over-year?
Stryker's medsurg and neurotechnology: — net sales increased by 4.9% year-over-year, from $3.06B to $3.21B.
What is the long-term trend for Stryker's medsurg and neurotechnology: — net sales?
Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology: — net sales has grown at a 12.3% compound annual growth rate (CAGR), from $9.54B to $15.19B.
What does medsurg and neurotechnology: — net sales mean?
Represents the total revenue generated from the sale of medical surgical equipment, neurotechnology devices, and related consumables within this specific business segment. This metric reflects the market demand and commercial success of the segment's product portfolio. It is a primary indicator of the segment's top-line growth and competitive positioning in the healthcare market.

Ask your AI about Stryker's medsurg and neurotechnology: — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude